|
|||||
|
|
Phase I study of the anti-MET antibody onartuzumab in patients with solid tumors and MET-positive lung cancer |
|
| Authors: | Makoto Nishio Atsushi Horiike Hiroshi Nokihara Hidehito Horinouchi Shinji Nakamichi Hiroshi Wakui Fumiyoshi Ohyanagi Keita Kudo Noriko Yanagitani Shunji Takahashi Yasutoshi Kuboki Noboru Yamamoto Yasuhide Yamada Masaichi Abe Takashi Tahata Tomohide Tamura |
| Affiliation: | 1. Department of Thoracic Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, Tokyo, 135-8550, Japan 2. National Cancer Center Hospital, Tokyo, Japan 3. Chugai Pharmaceutical Co., Ltd., Tokyo, Japan |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |